Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

134.22
Delayed Data
As of Jul 21
 +0.43 / +0.32%
Today’s Change
75.52
Today|||52-Week Range
153.15
+33.86%
Year-to-Date
The Best- and Worst-Performing Stocks of Last Decade
Jul 16 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close133.79
Today’s open133.02
Day’s range133.02 - 135.43
Volume755,991
Average volume (3 months)1,880,665
Market cap$27.5B
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-239.75%
Earnings growth (next 5 years)+98.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book60.43

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.98+1.53%
ZTSZoetis Inc+0.41+0.65%
MYLMylan NV-0.32-0.81%
BAXBaxter International...-0.37-0.59%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts